Sanofi-Aventis To Appeal Lovenox Verdict
Sanofi-Aventis will appeal a district court's ruling that its patent for anti-clotting drug Lovenox is unenforceable, Sanofi-Aventis' chief executive said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article